Jim Cramer's key to Wednesday's market — plus, relief for Intel after a concerning report

The 10-year Treasury yield reached its highest level since 2002 ahead of a 1 p.m. ET auction; Jim Cramer said a successful auction and lower yields could help the S&P 500 reverse declines, while higher yields and oil prices weighed on stocks. Intel shares were modestly higher after CEO Lip-Bu Tan said the company would continue working with Elon Musk on SpaceX’s Terafab project in Texas. Goldman Sachs and Citi raised FedEx price targets, while BMO and Truist cut targets for FedEx Freight; commentary said lower oil prices would benefit both.

Analysis

The auction is a near-term rates catalyst, not a durable equity signal by itself. If yields retreat, the relief trade may favor rate-sensitive growth and cyclicals; if they rise, valuation pressure can outweigh the defensive earnings profile of healthcare. LLY, JNJ and CAH may hold up relatively, but that is not a reason to treat them as bond proxies: drug-specific execution and valuation remain important, and high real yields can still compress multiples.

Intel’s Terafab narrative offers sentiment support, but the investable question is whether Intel secures a defined, economically meaningful manufacturing role—not whether it remains associated with the project. Until commitments, capacity, timing and customer economics are disclosed, a short-covering bounce is more defensible than underwriting a foundry rerating. TSM’s possible sublease is not evidence of lost business or a confirmed Intel win.

For transport, higher diesel creates a margin headwind whose severity depends on fuel-surcharge recovery, timing and shipment demand. A FDX-versus-UPS bet based on a long-run size claim is premature; FDXF also has distinct standalone execution and valuation risks after separation, so do not conflate it with FDX. Over 1–3 months, watch fuel trends, surcharge realization and guidance. Over 6–18 months, the key tests are Intel foundry customer conversion and the separated freight business’s operating performance. The contrarian risk is that investors overread both the Terafab endorsement and analyst target changes as evidence of realized earnings improvement.

Key Decisions for Investors

• Do not initiate a broad directional position solely around the Treasury auction. If yields move sharply higher and equities weaken, consider a limited-duration index hedge; unwind the thesis if yields reverse and the market stabilizes.
• Treat INTC strength as event-driven until Intel or project counterparties disclose binding scope, capacity, timing and economics. Reassess on verifiable customer commitments; thesis weakens if TSM assumes the substantive manufacturing role or Intel’s foundry guidance deteriorates.
• Keep FDX and FDXF exposure analytically separate. Before taking a transport position, verify diesel prices, surcharge lag/recovery, shipment trends and standalone FDXF guidance; improving oil alone is not sufficient confirmation.
• For a relative defensive tilt, monitor CAH/JNJ against fuel-sensitive transport exposure rather than assuming healthcare is immune to higher yields. Falsify the tilt if yields fall materially or company-specific earnings/guidance weaken.